Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 7849294)

Published in Blood on February 15, 1995

Authors

R A Baiocchi1, M E Ross, J C Tan, C C Chou, L Sullivan, S Haldar, M Monne, M V Seiden, S K Narula, J Sklar

Author Affiliations

1: Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY.

Articles citing this

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest (1995) 1.71

Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. J Virol (2005) 1.50

c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells. Blood (2005) 1.36

Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines. J Clin Invest (1996) 1.23

Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg (2000) 1.22

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. J Clin Invest (2000) 1.01

GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder. J Clin Invest (2001) 0.88

Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin Immunopathol (1998) 0.85

Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts. Am J Pathol (1997) 0.85

The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease. Oncotarget (2015) 0.83

In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors. Clin Exp Immunol (2001) 0.82

The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment. Curr Hematol Malig Rep (2015) 0.82

Humanized mouse models of epstein-barr virus infection and associated diseases. Pathogens (2013) 0.78

Articles by these authors

TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell (1991) 10.06

Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A (1985) 7.98

Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci U S A (2000) 7.67

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell (1986) 7.34

Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J (1990) 5.08

Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med (1996) 4.79

Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell (1998) 4.44

Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients. N Engl J Med (1995) 4.37

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2011) 4.31

Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA (2001) 4.30

Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci U S A (1984) 3.91

Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med (1989) 3.76

Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med (1998) 3.45

CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity (2000) 3.28

Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis (1992) 3.27

Calcium depletion dissociates and activates heterodimeric notch receptors. Mol Cell Biol (2000) 3.15

Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J Immunol (2001) 3.13

AIDS--beyond education. Med J Aust (1992) 3.09

Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med (1987) 3.07

Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription. J Biol Chem (1997) 2.93

Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol (1987) 2.74

Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature (1995) 2.74

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med (1988) 2.63

Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci (1997) 2.62

Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci (1997) 2.55

Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A (2001) 2.54

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49

A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest (1997) 2.37

Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res (1994) 2.31

Ecteinascidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: multicenter phase II and pharmacokinetic study. J Clin Oncol (2005) 2.24

Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med (1986) 2.21

Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med (2000) 2.21

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest (1993) 2.18

Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A (2001) 2.16

Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription. EMBO J (1988) 2.15

Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor. Mol Cell Biol (1997) 2.12

Bovine tuberculosis in free-ranging white-tailed deer from Michigan. J Wildl Dis (1997) 2.09

Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy. J Clin Oncol (2004) 2.08

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med (1991) 2.08

Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J Exp Med (2001) 2.07

CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. J Infect Dis (1994) 2.04

Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet (1984) 2.03

Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood (1999) 2.02

Hemophilus aegyptius restriction edonuclease cleavage map of the simian virus 40 genome and its colinear relation with the hemophilus influenzae cleavage map of SV40. J Mol Biol (1974) 2.01

Alterations of IgM, IgG, and IgA Synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease. Gastroenterology (1981) 1.98

Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol (1993) 1.98

An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health (2003) 1.96

Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J Antimicrob Chemother (1991) 1.96

Foot infections in diabetic patients. Decision and cost-effectiveness analyses. JAMA (1995) 1.95

Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol (1999) 1.93

Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell (1986) 1.92

The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod (1998) 1.83

Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvases. Nat Genet (1995) 1.79

Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (2008) 1.79

Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med (1984) 1.78

Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex. J Neurosci (2000) 1.76

Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. Am J Transplant (2015) 1.76

Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res (1992) 1.75

Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation. Curr Cancer Drug Targets (2003) 1.75

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest (1995) 1.71

Characterization and differential expression of human vascular smooth muscle myosin light chain 2 isoform in nonmuscle cells. Biochemistry (1989) 1.70

mRNA species regulated during the differentiation of HL-60 cells to macrophages and neutrophils. Dev Biol (1987) 1.70

Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ Res (2001) 1.69

Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med (1985) 1.68

Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions. Cancer Res (1994) 1.63

Cerebellar histogenesis is disturbed in mice lacking cyclin D2. Development (1999) 1.61

Functional analysis of the TAN-1 gene, a human homolog of Drosophila notch. Cold Spring Harb Symp Quant Biol (1994) 1.61

Abortion, illegitimacy, and the American birth rate. Science (1974) 1.61

Porous materials for thermal management under extreme conditions. Philos Trans A Math Phys Eng Sci (2006) 1.59

LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum Mol Genet (1998) 1.57

Continual requirement for a host RNA polymerase component in a bacteriophage development. Nature (1969) 1.57

Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer. J Clin Oncol (2002) 1.55

Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol (1998) 1.55

Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res (1992) 1.54

Reduced nicotinamide-adenine dinucleotide phosphate dependent biliverdin reductase: partial purification and characterization. Biochemistry (1970) 1.53

Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med (1986) 1.53

First Fracture Project: addressing the osteoporosis care gap. Intern Med J (2007) 1.49

Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res (1990) 1.48

Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J (1995) 1.48

The importance of osmolality in hydrophilic urethral catheters: a crossover study. Spinal Cord (1997) 1.47

BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. Proc Natl Acad Sci U S A (1990) 1.47

Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Clin Oncol (1992) 1.47

Development and testing of a new measure of case mix for use in office practice. Med Care (1995) 1.45

The effect of physical training on insulin production in obesity. Metabolism (1970) 1.45

The 5'-terminal nucleotide sequence of galactose messenger ribonucleic acid of Escherichia coli. Proc Natl Acad Sci U S A (1974) 1.44

Immunoglobulin gene rearrangements in Hodgkin's disease. Hum Pathol (1986) 1.43

Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer (1999) 1.43

X-linked malformations of neuronal migration. Neurology (1996) 1.42

Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N Engl J Med (1985) 1.40

Primary extranodal lymphoma: response to treatment and factors influencing prognosis. Cancer (1978) 1.40

Management of alkali burns : an 11-year retrospective review. Ophthalmology (2000) 1.40

Impaired immune function in a premature infant with zinc deficiency after total parenteral nutrition. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi (1997) 1.38

Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B-cell clones. Science (1985) 1.38

Structure and expression of ferritin genes in a human promyelocytic cell line that differentiates in vitro. Mol Cell Biol (1986) 1.37

Stimulating cell types in the autologous mixed leukocyte reaction in man. J Immunol (1980) 1.36

Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation. Clin Immunol Immunopathol (1988) 1.36

Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells (1990) 1.36

Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J Biol Chem (2000) 1.35

Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res (1999) 1.34